Insider Trading & Ownership of Kenneth Bate

Location: C/O Millennium Pharmaceuticals Inc, 40 Landsdowne Street, Cambridge, MA
Summary: The estimated net worth of Kenneth Bate is at least $1.3M dollars as of November 7, 2025. Kenneth Bate is the Director of MADRIGAL PHARMACEUTICALS, INC. and owns shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) stock worth about $1.29M. Kenneth Bate is the Director of AVEO PHARMACEUTICALS, INC. and owns shares of AVEO PHARMACEUTICALS, INC. stock worth about $5.63K.
Signature: /s/ Mardi Dier, as Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Kenneth Bate files a new Insider Trading report.

Ownership of Kenneth Bate

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
MDGL	MADRIGAL PHARMACEUTICALS, INC.	Director	$1.29M	-$18.8M	-93.6%	Nov 5, 2025
AVEO	AVEO PHARMACEUTICALS, INC.	Director	$5.63K			Jan 19, 2023
ATXS	Astria Therapeutics, Inc.	Director				Jun 11, 2025
EPZM	Epizyme, Inc.	Director				Aug 12, 2022
GNCA	GENOCEA BIOSCIENCES, INC.	Director				Jul 1, 2021

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.